Varian Medical Systems Inc (VAR) Return on Equity ROE from the first quarter 2021 to first quarter 2020 and annually, average high and low, overall ranking from Jan 01 2021 to Jan 03 2020 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Varian Medical Systems Inc   (NYSE: VAR)

Varian Medical Systems Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Varian Medical Systems Inc in the first quarter 2021?
Varian Medical Systems Inc achieved a return on average equity (ROE) of 13.62 % in its first quarter 2021, which is below Varian Medical Systems Inc 's average return on equity, which stands at 21.66%.

ROE fell compared to the fourth quarter 2020, despite the net income growth of 26.54% from the fourth quarter 2020.

Within the Medical Equipment & Supplies industry 27 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the fourth quarter 2020 from 767 to 898.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jan 01 2021)
I. Quarter		 (Oct 02 2020)
IV. Quarter		 (Jul 03 2020)
III. Quarter		 (Apr 03 2020)
II. Quarter		 (Jan 03 2020)
I. Quarter
Y / Y Equity Change 21.03 % 17.28 % 10.57 % 7.51 % -
Y / Y Net Income Change 8.89 % 31.67 % 106.44 % -51.24 % -14.44 %
Net Income (TTM) in Millions 277 269 251 220 265
Return On Equity (TTM) 13.62 % 13.89 % 13.48 % 12.09 % 14.86 %
VAR's Total Ranking # 898 # 767 # 799 # 937 # 967
Equity (TTM) in Millions 2,248 2,085 1,943 1,871 1,857
Seq. Equity Change 7.82 % 7.29 % 3.87 % 0.72 % 4.48 %
Seq. Net Income Change 26.54 % 25.62 % 41.3 % -51.52 % 53.01 %

Back to VAR Management Effectiveness >> VAR's 5 Years Annual ROE >> Compare VAR ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 28
Sector # 130
Overall # 898

Return On Equity Statistics
High Average Low
28.25 %
21.66 %
6.15 %
(Sep. 30, 2012)   (Dec 29 2017)





VAR Annual Return On Equity (Oct 02 2020)
2020		 (Sep 27 2019)
2019		 (Sep 28 2018)
2018		 (Sep 29 2017)
2017		 (Sep 30 2016)
2016
Total Equity in Millions 2,085 1,778 1,589 1,499 1,744
Y / Y Equity Change 17.28 % 11.89 % 5.96 % -14.04 % 1.03 %
Net Income in Millions 269 292 150 250 403
Y / Y Net Income Change -7.8 % 94.41 % -39.95 % -37.84 % -2.26 %
Return On Equity 12.92 % 16.44 % 9.46 % 16.69 % 23.09 %

Back to VAR Management Effectiveness >> VAR's 5 Years Annual ROE >> Compare VAR ROE to its Competitors




Annual Roe Comment
In 2020 ROE decreased compared to the previous year to 12.92 %, due to deterioration of net income.


More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
VAR's' Return on Equity at Yahoo Finance
VAR's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for VAR's Competitors
Subscribers only: Roe for Varian Medical Systems Inc 's Suppliers
Subscribers only: Return On Equity for VAR's Customers




Companies with similar Return On Equity at Jan 01 2021, within Healthcare Sector ROE
Dexcom Inc   36.98 %
Lifevantage Corp  36.36 %
Pro dex Inc   36.16 %
Biogen Inc   35.89 %
Progyny Inc   35.26 %
Vertex Pharmaceuticals Inc  35.21 %
Purple Biotech Ltd  35.20 %
Bionexus Gene Lab Corp   34.37 %
Regeneron Pharmaceuticals Inc   33.19 %
Lakeland Industries Inc   32.69 %
Blueprint Medicines Corporation  30.97 %
Voyager Therapeutics Inc   30.80 %
Select Medical Holdings Corp  29.84 %
Pacira Biosciences inc   29.60 %
Inmode Ltd   29.37 %
Meridian Bioscience Inc   29.09 %
Resmed Inc   28.15 %
Biodelivery Sciences International Inc   28.14 %
Prestige Consumer Healthcare Inc   27.23 %
Glucotrack Inc   26.76 %
Seagen Inc   26.32 %
Organogenesis Holdings Inc   26.08 %
Xoma Royalty Corporation  26.08 %
Merck and Co Inc   26.06 %
Amedisys Inc  24.93 %
Emergent Biosolutions Inc   24.54 %
Quest Diagnostics Inc  24.14 %
Magellan Health inc   23.81 %
Biomarin Pharmaceutical Inc  23.48 %
Royalty Pharma Plc  23.40 %

Date modified: 2026-09-26T07:00:31+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.